AKT1 and cancer: The NF-κB signalling pathway has been implicated in CCL5-induced EMT changes in ovarian non-cancer stem-cell-like cells [67] and the AKT/ERK pathway was reported to be activated by CXCR7 and its ligand CCL19 in studies by Yu et al. [68] and Cheng et al. [69].